Martin ONeill - Cabot Senior Affairs

CBT Stock  USD 109.82  1.15  1.06%   

Executive

Martin ONeill is Senior Affairs of Cabot
Address Two Seaport Lane, Boston, MA, United States, 02210-2019
Phone617 345 0100
Webhttps://www.cabotcorp.com

Cabot Management Efficiency

The company has Return on Asset of 0.1073 % which means that on every $100 spent on assets, it made $0.1073 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.283 %, implying that it generated $0.283 on every 100 dollars invested. Cabot's management efficiency ratios could be used to measure how well Cabot manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to 0.05 in 2024. Return On Capital Employed is likely to drop to 0.15 in 2024. Non Current Liabilities Other is likely to gain to about 216.1 M in 2024, whereas Total Current Liabilities is likely to drop slightly above 600.9 M in 2024.
Cabot has 1.14 B in debt with debt to equity (D/E) ratio of 1.4, which is OK given its current industry classification. Cabot has a current ratio of 1.62, which is typical for the industry and considered as normal. Note however, debt could still be an excellent tool for Cabot to invest in growth at high rates of return.

Similar Executives

Showing other executives

EXECUTIVE Age

Alex HowarthMadrigal Pharmaceuticals
55
Brian JDMadrigal Pharmaceuticals
62
Carole HuntsmanMadrigal Pharmaceuticals
59
Ronald FilippoMadrigal Pharmaceuticals
N/A
Kelly CarterGold Fields Ltd
N/A
Chirfi GuindoMerck Company
58
Joshua MortotiGold Fields Ltd
52
Tina VenturaMadrigal Pharmaceuticals
N/A
Shai ShaharFormFactor
52
Alan ChanFormFactor
47
Gideon BlumenthalMerck Company
N/A
Joerg KoglinMerck Company
N/A
Wade JenkeAmtech Systems
N/A
Thomas MengelGold Fields Ltd
N/A
Aasutosh DaveFormFactor
N/A
Shannon KelleyMadrigal Pharmaceuticals
N/A
Luis MBAGold Fields Ltd
59
Jennifer JDMerck Company
46
Francois SwanepoelGold Fields Ltd
51
Chun LyuEshallgo Class A
40
Clint WallaceMadrigal Pharmaceuticals
N/A
Cabot Corporation operates as a specialty chemicals and performance materials company. Cabot Corporation was founded in 1882 and is headquartered in Boston, Massachusetts. Cabot Corp operates under Specialty Chemicals classification in the United States and is traded on New York Stock Exchange. Cabot (CBT) is traded on New York Stock Exchange in USA. It is located in Two Seaport Lane, Boston, MA, United States, 02210-2019 and employs 28 people. Cabot is listed under Commodity Chemicals category by Fama And French industry classification.

Management Performance

Cabot Leadership Team

Elected by the shareholders, the Cabot's board of directors comprises two types of representatives: Cabot inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Cabot. The board's role is to monitor Cabot's management team and ensure that shareholders' interests are well served. Cabot's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Cabot's outside directors are responsible for providing unbiased perspectives on the board's policies.
Jeff Zhu, Senior Vice President and President Performance Additives business and President Asia Pacific Region
Steven Delahunt, VP Treasurer
Vanessa Craigie, Corporate Director
Sue Rataj, Non-Executive Chairman of the Board
Aaron Johnson, Senior Inkjet
Karen Kalita, Senior Vice President General Counsel
Jaume Campana, SVP Segment
Erica CPA, CFO VP
Cynthia Arnold, Independent Director
Martin ONeill, Senior Affairs
Juan Enriquez, Independent Director
Douglas Grosso, Independent Director
Matthias Wolfgruber, Independent Director
Lisa Dumont, Principal Accounting Officer, Controller
Sean Keohane, Executive VP and President of Reinforcement Materials Segment
Patricia Hubbard, Senior Vice President, Chief Technology Officer
Karen JD, Senior Counsel
Susan Rataj, Non-Executive Independent Chairman of the Board
Doug Grosso, Independent Director
Mark Wrighton, Independent Director
Jane Bell, Secretary
Erica McLaughlin, Chief Financial Officer, Senior Vice President
Arthur Wood, Senior Officer
Michael Morrow, Independent Director
Christine Yan, Independent Director
William Kirby, Independent Director
Hobart Kalkstein, Senior Vice President and President - Reinforcement Materials Segment, and President, Americas Region
Frank Wilson, Independent Director

Cabot Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Cabot a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Cabot Stock Analysis

When running Cabot's price analysis, check to measure Cabot's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cabot is operating at the current time. Most of Cabot's value examination focuses on studying past and present price action to predict the probability of Cabot's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cabot's price. Additionally, you may evaluate how the addition of Cabot to your portfolios can decrease your overall portfolio volatility.